Model for a factor IX activation complex on blood platelets: Dimeric conformation of factor XIa is essential

Blood

Volumn 97, Issue 10, 2001, Pages 3117-3122

  Gailani, David ^a,b   Ho, David ^a,b   Sun, Mao Fu ^a,b   Cheng, Qiufang ^a,b   Walsh, Peter N ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 9; KAOLIN; PREKALLIKREIN;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; BLOOD CLOTTING; CARBOXY TERMINAL SEQUENCE; DISULFIDE BOND; ENZYME STRUCTURE; HUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PURIFICATION; STRUCTURE ANALYSIS; SURFACE PROPERTY; THROMBOCYTE; THROMBOCYTE ACTIVATION; WESTERN BLOTTING;

EID: 0035874505     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.10.3117     Document Type: Article

References (38)

1. Mann K, Jenny R, Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem. 1988;57:915-956.
2. Mann K, Nesheim M, Church W, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood. 1990;76:1-16.
3. Davie E, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance and regulation. Biochemistry. 1991;30:10363-10370.
4. Furie B, Furie B. Molecular and cellular biology of blood coagulation. N Engl J Med. 1992;326:800-806.
5. Rapaport S, Rao L. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb. 1992;12:1111-1121.
6. Osterud B, Bouma B, Griffin G. Human blood coagulation factor IX: purification, properties, and mechanism of activation by activated factor XI. J Biol Chem. 1978;253:5946-5951.
7. DiScipio R, Kurachi K, Davie E. Activation of human factor IX (Christmas factor). J Clin Invest. 1978;61:1528-1538.
8. Walsh P, Bradford H, Sinha D, Piperno J, Tuszynski G. Kinetics of the factor XIa catalyzed activation of human coagulation factor IX. J Clin Invest. 1984;73:1392-1399.
9. Mannhalter C, Schiffman S, Deutsch E. Phospholipids accelerate factor IX activation by surface bound factor XIa. Brit J Haematol. 1984;56:261-271.
10. Limentani S, Furie B, Furie B. The biochemistry of factor IX. In: Colman R, Hirsh J, Marder V, Salzman E, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd ed. Philadelphia, PA: JB Lippincott; 1994:94-108.
11. Sinha D, Seaman F, Koshy A, Walsh P. Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that of factor XI. J Clin Invest. 1984;73:1550-1559.
12. Greengard J, Heeb M, Ersdal E, Walsh P, Griffin J. Binding of coagulation factor XI to washed human platelets. Biochemistry. 1986;25:3884-3890.
13. Baglia F, Walsh P. Prothrombin is a cofactor for binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin. Biochemistry. 1998;37:2271-2281.
14. Baglia F, Walsh P. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa. J Biol Chem. 2000;275:20514-20519.
15. Ho D, Badellino K, Baglia F, et al. The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface. J Biol Chem. 2000;275:25139-25145.
16. Seligsohn U, Griffin J. Contact activation and factor XI. In: Scriver CR, Beadet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995:3289-3311.
17. Ahmad S, Rawala-Sheikh R, Walsh P. Comparative interactions of factor IX and factor IXa with human platelets. J Biol Chem. 1989;264:3244-3251.
18. Bouma B, Griffin J. Human blood coagulation factor XI, purification, properties, and mechanism of activation by activated factor XII. J Biol Chem. 1977;252:6432-6437.
19. Fujikawa K, Chung D, Hendrickson L, Davie E. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry. 1986;25:2417-2424.
20. McMullen B, Fujikawa K, Davie E. Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains. Biochemistry. 1991;30:2056-2060.
21. Chung D, Fujikawa K, McMullen B, Davie E. Human plasma prekallikrein, a zymogen to a serine protease that contains four tandem repeats. Biochemistry. 1986;25:2410-2417.
22. McMullen B, Fujikawa K, Davie E. Location of the disulfide bonds in human plasma prekallikrein: presence of four novel apple domains in the amino-terminal portion of the molecule. Biochemistry. 1991;30:2050-2056.
23. Sun M-F, Zhao M, Gailani D. Identification of amino acids on the factor XI apple 3 domain required for activation of factor IX. J Biol Chem. 1999;274:36373-36378.
24. Baglia F, Jameson B, Walsh P. Identification and chemical synthesis of a substrate binding site for factor IX on coagulation factor XIa. J Biol Chem. 1991;266:24190-24197.
25. Ho D, Baglia F, Walsh P. Factor XI binding to activated platelets is mediated by residues R (250), K (255), F (260), and Q (263) within the apple 3 domain. Biochemistry. 2000;39:316-323.
26. Gailani D, Sun M-F, Ho D, Zhao M, Cheng Q, Walsh P. A model for the activation of factor IX by factor XIa on the surface of platelets. Blood. 1999;94:621a.
27. Sun Y, Gailani D. Identification of a factor IX binding site on the third apple domain of activated factor XI. J Biol Chem. 1996;271:29023-29028.
28. Gailani D, Broze G. Effects of glycosaminoglycans on factor XI activation by thrombin. Blood Coagul Fibrinolysis. 1993;4:15-20.
29. Kerbiriou D, Griffin J. High molecular weight kininogen: studies of structure-function relationships and of proteolysis of the molecule during contact activation of plasma. J Biol Chem. 1979;254:12020-12207.
30. Gailani D, Sun M, Sun Y. A comparison of murine and human factor XI. Blood. 1997;90:1055-1064.
31. Sinha D, Koshy A, Seaman F, Walsh P. Functional characterization of human blood coagulation factor XIa using hybridoma antibodies. J Biol Chem. 1985;260:10714-10719.
32. Bell W, Alton H. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature. 1954;174:880-881.
33. Baglia F, Jameson B, Walsh P. Identification and characterization of a binding site for platelets in the apple 3 domain of coagulation factor XI. J Biol Chem. 1995;270:6734-6740.
34. Meijers J, Mulvihill E, Davie E, Chung D. Apple 4 in human blood coagulation factor XI mediates dimer formation. Biochemistry. 1992;31:4680-34684.
35. Meijers J, Davie E, Chung D. Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood. 1992;79:1435-1440.
36. Pugh R, McVey J, Tuddenham E, Hancock J. Six point mutations that cause factor XI deficiency. Blood. 1995;85:1509-1516.
37. Stenflo J, Dahlback B. Vitamin-K dependent proteins. In: Stamatoyannopoulos G, Nienhuis A, Majerus P, Varmus H, eds. The Molecular Basis of Blood Diseases. 2nd ed. Philadelphia, PA: WB Saunders; 1994:565-589.
38. Wolberg A, Morris D, Stafford D. Factor IX activation by factor XIa proceeds without release of a free intermediate. Biochemistry. 1997;36:4074-4079.